What is the appropriate Bromfed (brompheniramine/pseudoephedrine) dose for a 47‑lb (≈21‑kg) child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bromfed Dosing for a 47-Pound Child

For a 47-pound (21-kg) child, Bromfed should not be used if under 2 years of age; for children 2 years and older, the typical dose is based on the brompheniramine component at 1-2 mg/kg/day divided into doses, which translates to approximately 2.5 mL (half of a 5 mL dose) of the liquid formulation every 4-6 hours, not exceeding 4 doses per day.

Dosing Calculation and Rationale

The evidence base for Bromfed dosing in children is limited, requiring extrapolation from FDA labeling and general pediatric antihistamine guidelines:

  • Weight-based calculation: At 21 kg, using the diphenhydramine dosing guideline of 1-2 mg/kg 1 as a reference for first-generation antihistamines, and considering brompheniramine's similar pharmacologic class, the child would require approximately 21-42 mg/day of brompheniramine total.

  • FDA labeling guidance: The Bromfed drug label 2, 3 indicates use in children ≥2 years old. Standard brompheniramine dosing is 4 mg every 4-6 hours in older children, but this must be adjusted downward for a 21-kg child.

  • Practical dosing: Bromfed liquid typically contains 1 mg brompheniramine per 5 mL. For a 21-kg child, 2.5 mL every 4-6 hours (maximum 4 times daily) provides approximately 10-20 mg/day of brompheniramine, which falls within the safe therapeutic range.

Critical Safety Considerations

Age Restrictions

  • Do not use in children under 2 years of age - the FDA label explicitly contraindicates this 2
  • Oral decongestants in young children have been associated with serious adverse events including agitated psychosis, ataxia, hallucinations, and death 4

Overdose Risk

The FDA label warns that toxic responses can occur with "apparently small amounts" in children 2. A 2.5-year-old child survived 300-900 mg of brompheniramine, but this represents a massive overdose - emphasizing the narrow therapeutic window in pediatrics.

Drug Interactions

Critical warning: If the child is on any serotonergic medications (SSRIs, other antidepressants), Bromfed DM formulations containing dextromethorphan can precipitate serotonin syndrome 5. Verify the specific Bromfed formulation being used.

Stimulant Considerations

The pseudoephedrine component can cause:

  • CNS stimulation, tachycardia, hypertension 2, 3
  • Interactions with ADHD medications if the child is taking stimulants 4
  • Insomnia, loss of appetite, irritability, palpitations 4

Pharmacokinetic Considerations in Children

Children eliminate these medications differently than adults:

  • Brompheniramine has a 12.4-hour half-life in children (mean age 9.5 years) with peak concentrations at 3.2 hours 6
  • Pseudoephedrine has a shorter half-life in children (3.1 hours) compared to adults 7
  • This means children may require more frequent dosing intervals than adults, but total daily doses must remain conservative

Monitoring Parameters

Watch for:

  • Anticholinergic effects: Dry mouth, urinary retention, constipation
  • CNS effects: Paradoxical excitation (especially in younger children), drowsiness, or stimulation
  • Cardiovascular effects: Tachycardia, elevated blood pressure
  • Respiratory depression: Particularly if combined with other sedating medications

When NOT to Use Bromfed

Avoid in children with:

  • Cardiovascular disease, hypertension
  • Hyperthyroidism
  • Closed-angle glaucoma
  • Bladder neck obstruction 4
  • Concurrent use of MAO inhibitors or SSRIs (if DM-containing formulation)

Alternative Considerations

Given the limited evidence for efficacy and significant safety concerns with combination cold medications in children, consider whether symptomatic treatment is truly necessary. Supportive care (hydration, humidification, saline nasal rinses) may be equally effective with fewer risks for common cold symptoms.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.